Latest Breaking News On - மக்டர்மட் விருப்பம் எமரீ - Page 1 : comparemela.com

Veristat Announces New Investment Partner-WindRose Health Investors Recapitalization Will Accelerate Strategic Growth to Help Sponsors Save and Improve the Lives of Patients Veristat, a scientific-minded, global clinical research organization (CRO), announced today that it transferred its majority ownership from Variance Development Partners to WindRose Health Investors (WindRose). WindRose invests exclusively in healthcare companies and has extensive experience across the healthcare services landscape, including outsourced biopharmaceutical services like Veristat s. As a founder of Veristat, I believe that Veristat has attained the ideal investment partner who understands our philosophy, our values, and the impact we make in clinical research, stated John P. Balser, Ph.D., President, Co-Founder, and Chief Statistical Officer of Veristat. WindRose has a track record of successful collaboration, understands the critical nature of the scientific and therapeutic expertise we

New yorkUnited statesJohnp balserKostenloser wertpapierhandelPatrick flanaganLauren brennanNutter mcclennen fishRecapitalization will accelerate strategic growthHelp sponsors saveVariance development partnersWindrose health investorsChief statistical officerChief executive officerMcdermott will emeryNew york cityபுதியது யார்க்